Efficacy News and Research

RSS
Positive results reported from Phase IIa clinical trial of intranasal oxytocin for CDH

Positive results reported from Phase IIa clinical trial of intranasal oxytocin for CDH

Visually-guided laser-balloon catheter stops abnormal electrical pulses in patients with irregular heartbeats

Visually-guided laser-balloon catheter stops abnormal electrical pulses in patients with irregular heartbeats

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

MAQUET Cardiovascular commences enrollment in trial of FUSION and FUSION BIOLINE Vascular Grafts

MAQUET Cardiovascular commences enrollment in trial of FUSION and FUSION BIOLINE Vascular Grafts

FDA grants priority review for Alkermes' VIVITROL sNDA for opioid dependence

FDA grants priority review for Alkermes' VIVITROL sNDA for opioid dependence

Spectrum Pharmaceuticals to present clinical data on belinostat at ASCO 2010

Spectrum Pharmaceuticals to present clinical data on belinostat at ASCO 2010

DMC recommends ARIAD continue Phase 3 trial of oral ridaforolimus for metastatic sarcomas to final analysis

DMC recommends ARIAD continue Phase 3 trial of oral ridaforolimus for metastatic sarcomas to final analysis

ImmunoGen to present clinical data on IMGN388 solid tumor compound at 2010 ASCO

ImmunoGen to present clinical data on IMGN388 solid tumor compound at 2010 ASCO

NovaBay Pharmaceuticals completes enrollment in Phase 2a trial of NVC-422 for treatment of impetigo

NovaBay Pharmaceuticals completes enrollment in Phase 2a trial of NVC-422 for treatment of impetigo

t2c001 product obtains certificate under EMA regulations for ATMPs

t2c001 product obtains certificate under EMA regulations for ATMPs

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Biogen Idec, Abbott commence enrollment in Phase III comparative study of daclizumab to AVONEX for RRMS

Biogen Idec, Abbott commence enrollment in Phase III comparative study of daclizumab to AVONEX for RRMS

ADDF provides $248,000 grant to ALSP to allow its lead drug candidate towards clinical trials

ADDF provides $248,000 grant to ALSP to allow its lead drug candidate towards clinical trials

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Preclinical results of AMEP for metastatic melanoma presented at ASGCT Annual Meeting

Preclinical results of AMEP for metastatic melanoma presented at ASGCT Annual Meeting

Positive results from Phase 2 clinical trial for STA-9090 in Stage IIIB and Stage IV patients with NSCLC

Positive results from Phase 2 clinical trial for STA-9090 in Stage IIIB and Stage IV patients with NSCLC

NormOxys raises $17.5M in Series B financing round

NormOxys raises $17.5M in Series B financing round

Phase 1 clinical trial of OXY111A initiated

Phase 1 clinical trial of OXY111A initiated

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.